Evaluation of a computer aid for assessing stomach symptoms

Phase II exploratory randomised controlled trial (RCT) comparing use of electronic clinical decision support (eCDS) for suspected oesophago-gastric cancer in primary care with usual care

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN12595588

Enrollment

3030

Registered

2015-06-10

Start date

2015-06-01

Completion date

Unknown

Last updated

2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Topic: Primary Care

Interventions

Participants are clustered (at the participating site level) to the intervention arm or usual care. Practices randomised to the intervention arm will be provided with the oesophagogas

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients presenting to the GP with symptoms associated with OG cancer (NICE clinical guidelines 17 & 27) 2. Aged 55 years and over 3. Target Gender: Male & Female 4. Aged 55-100

Exclusion criteria

Exclusion criteria: 1. Inability to understand study documentation, for instance because of a lack of English fluency 2. Patients unable to provide informed consent

Design outcomes

Primary

Measure	Time frame
Feasibility; Timepoint(s): 6 months	—

Secondary

Measure	Time frame
All measured at six months from patient recruitment, and will be taken from patient notes (primary and secondary care). 1. Practitioner outcomes: frequency and sustainability of use of eRAT, adherence to recommendations, attitudes to and role of eCDS. 2. Service outcomes: referral rates; use of diagnostic pathways (2WW and direct access gastroscopy, conversion (proportion of referrals with cancer diagnosis) and detection rates (proportion of OG cancers referred through these routes); Time from first consultation to diagnosis with cancer (diagnostic interval) 3. Health economic outcomes based on estimates of resource use 4. Patient outcomes: acceptability of use of eCDS	—

Measure

Time frame

All measured at six months from patient recruitment, and will be taken from patient notes (primary and secondary care). 1. Practitioner outcomes: frequency and sustainability of use of eRAT, adherence to recommendations, attitudes to and role of eCDS. 2. Service outcomes: referral rates; use of diagnostic pathways (2WW and direct access gastroscopy, conversion (proportion of referrals with cancer diagnosis) and detection rates (proportion of OG cancers referred through these routes); Time from first consultation to diagnosis with cancer (diagnostic interval) 3. Health economic outcomes based on estimates of resource use 4. Patient outcomes: acceptability of use of eCDS

—

Countries

England, United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 13, 2026